Error: Could not add to watchlist. X
+ Watchlist

Carnegie Fund II - Biotechnology Sub-Fund

CARBIOA:LX
30.20
EUR
As of 12:00 AM EST 2/24/2017
Fund Type
SICAV
52Wk Range
21.28 - 30.71
1 Yr Return
27.27%
YTD Return
10.91%
Before it's here, it's on the Bloomberg Terminal.
Learn More
52Wk Range
21.28 - 30.71
1 Yr Return
32.46%
YTD Return
10.91%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 02/24/2017)
30.2
Total Assets (m EUR) (on 11/30/2016)
27.608
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%

Top Fund Holdings

Name Position Value % of Fund
3.55 k 905.23 k 7.81
7.68 k 813.29 k 7.02
7.10 k 787.54 k 6.79
11.81 k 782.10 k 6.75
7.00 k 558.74 k 4.82
4.10 k 490.59 k 4.23
6.01 k 467.91 k 4.04
2.95 k 427.97 k 3.69
6.68 k 389.22 k 3.36
2.40 k 368.05 k 3.17
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
Address
Carnegie Fonder
Box 7828
103 97 Stockholm
Sweden
Phone
46-08-12-15-50-00 Tel